fda glp-1 compounding crackdown news on off-brand Ozempic products set to take effect, threatening supply and access for many FDA is moving to restrict
Description
GLP-1s are diabetes drugs that are exploding in popularity because of their weight loss properties
Doctors also caution that the rising demand could exacerbate shortages for diabetes patients who rely on the drug
Fragmented care, such as receiving prescriptions from specialists without informing primary care providers, can further disrupt continuity in therapy
When it comes to managing chronic conditions like type 2 diabetes and obesity, semaglutide has emerged as a game-changer
I farmaci GLP-1 RA promettono di rivoluzionare la terapia del diabete e dellobesit, data la loro notevole efficacia
They work
